编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
---|---|---|---|---|
161227107 | Leukadherin-1 | 344897-95-6 | 98% | |
Leukadherin-1 (LA1) is a small molecule agonist that enhances CD11b/CD18-dependent ce | ||||
16122765 | Ledipasvir (GS5885) | 1256388-51-8 | 98% | |
Ledipasvir (GS5885) is a HCV NS5A polymerase inhibitor, used for the treatment of hep | ||||
16122739 | LLY-507 | 1793053-37-8 | 98% | |
LLY-507 is a cell-active, potent, and selective inhibitor of protein-lysine Methyltra | ||||
16122736 | Lirametostat ( CPI-1205 ) | 1621862-70-1 | ≧98.0% | |
Lirametostat ( CPI-1205 ) 是一种有效的、选择性的、辅助因子竞争性的 | ||||
16122732 | L755507 | 159182-43-1 | 98% | |
L-755,507 is characterized as a potent and selective 3 adrenergic receptor partial ag | ||||
16122722 | LY333531 | 169939-93-9 | 98% | |
LY333531 is a -specific protein kinase C inhibitor. It competitively and reversibly i | ||||
6111410 | Lenalidomide hydrochloride | 1243329-97-6 | 98% | |
Lenalidomide (Revlimid, CC-5013) is a TNF- secretion inhibitor with IC50 of 13 nM | ||||
6111409 | Lenalidomide hemihydrate | 847871-99-2 | 98% | |
Lenalidomide (Revlimid, CC-5013) is a TNF- secretion inhibitor with IC50 of 13 nM.Len | ||||
61123 | LOXO-101 | 1223405-08-0 | 98% | |
LOXO-101 is an oral potent and selective ATP-competitive inhibitor of tropomyosin rec | ||||
61120 | LPA2 antagonist 1 | 1017606-66-4 | 98% | |
LPA2 antagonist 1 is a selective inhibitor of LPA2 activity in with IC50 17 nM in vit | ||||
6111018 | Liproxstatin-1 | 950455-15-9 | 98% | |
Liproxstatin-1 | ||||
6111006 | Lasmiditan | 439239-90-4 | 98% | |
Lasmiditan (COL-144; LY573144) is a high-affinity, highly selective 5-HT1F receptor a | ||||
6111005 | Lasmiditan hydrochloride | 613677-28-4 | 98% | |
Lasmiditan (COL-144; LY573144) is a high-affinity, highly selective 5-HT1F receptor a | ||||
611944 | Litronesib | 910634-41-2 | 98% | |
Litronesib is a selective, allosteric inhibitor of Eg5, which may result in mitotic d | ||||
611819 | LY 303511 hydrochloride | 98% | ||
LY303511 Hcl, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhi | ||||
611818 | LY 303511 | 154447-38-8 | 98% | |
LY303511, an inactive analogue of LY294002, is a mTOR inhibitor that did not inhibit | ||||
611808 | LY3023414 | 1386874-06-1 | 98% | |
LY3023414 is an oral ATP competitive inhibitor of the class I PI3K isoforms, mTOR and | ||||
16071412 | Lifitegrast | 1025967-78-5 | 98% by HPLC | |
Lifitegrast, also known as SAR-1118, is an LFA-1 antagonist intended for the treatmen | ||||
16071008 | Lonafarnib | 193275-84-2 | 98% by HPLC | |
Lonafarnib is a farnesyl transferase inhibitor. Structurely, it is also a synthetic t | ||||
16070904 | LJI308 | 1627709-94-7 | 98% by HPLC | |
LJI308 is a potent, and pan-RSK(p90 ribosomal S6 kinase) inhibitor withIC50of 6 nM, 4 | ||||
16070903 | LJH685 | 1627710-50-2 | 98% by HPLC | |
LJH685 is a potent pan-RSKinhibitor withIC50of 6 nM, 5 nM and 4 nM for RSK1, RSK2, an | ||||
16062301 | LX1606 (Hippurate) | 1137608-69-5 | 98% by HPLC | |
LX1606 is an orally bioavailable, small-molecule, tryptophan hydroxylase (TPH) inhibi | ||||
632801 | Lumateperone(ITI-007) | 313368-91-1 | 98% | |
ITI-007 is an investigational atypical antipsychotic which is currently under develop | ||||
030907 | LGD-4033(Ligandrol) | 1165910-22-4 | 98% | |
LGD-4033, also known as VK5211 and Ligandrol, is an investigational selective androge | ||||
011904 | LY-379268 | 191471-52-0 | 98% | |
Coming soon! | ||||
011808 | Lefamulin acetate | 1350636-82-6 | 98% | |
Coming soon! | ||||
011807 | Lefamulin | 1061337-51-6 | 98% | |
Coming soon! | ||||
011316 | L-165041 | 79558-09-1 | 98% | |
Coming soon! | ||||
010819 | Linsitinib | 867160-71-2 | 98% | |
Linsitinib is highly potent, orally efficacious and highly selective, dual ATP-compet | ||||
010815 | Lestaurtinib | 111358-88-4 | 98% | |
Lesraurtinib is an orally bioavailable indolocarbazole derivative with antineoplastic |